Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
02/2003
02/20/2003WO2002029088A9 Highly expressible genes
02/20/2003WO2002028420A9 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules
02/20/2003WO2002026950A3 Transferases
02/20/2003WO2002026193A9 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
02/20/2003WO2002022783A8 Liver gene expression associated with the inhibition of hbv replication or transcription
02/20/2003WO2002014368A8 Proteins and nucleic acids encoding the same
02/20/2003WO2002012452A3 Pancreatic progenitor cells
02/20/2003WO2001064949A9 Diagnostics and therapeutics for glaucoma
02/20/2003WO2001047944A3 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
02/20/2003US20030037350 Nucleotide sequences coding polypeptides for use in the treatment and diagnosis of cancer and nervous system disorders
02/20/2003US20030037345 Compositions and methods for wound healing
02/20/2003US20030036649 2' modified oligonucleotides
02/20/2003US20030036646 Uncoupling protein polynucleotides, polypeptides, and antibodies
02/20/2003US20030036645 Breast cancer resistance protein (BCRP) and the DNA which encode it
02/20/2003US20030036642 Platelet derived growth factor (PDGF) nucleic acid ligand complexes
02/20/2003US20030036633 DNA encoding bradykinin B1 receptor
02/20/2003US20030036568 Permeation enhancers
02/20/2003US20030036525 Hyaluronic acid and/or a salt thereof associated with/bound with an effective amount of anti-sense to the gene implicated in the disease or condition
02/20/2003US20030036524 Transfecting with a polynucleotide that comprises a prodrug metabolising gene, and a promoter capable of selectively promoting the transcription of the prodrug metabolising gene in said endothelial cell; and delivering said prodrug
02/20/2003US20030036520 Contacting the gastrointestinal site of delivery with an agent that causes a temporary disruption of the mucosal lining; and concurrently or subsequently contacting with a nucleic acid or a cell comprising a nucleic acid
02/20/2003US20030036518 Artificial polymeric membrane structure, method for preparing same, method for preparing this polymer, particle and film containing this structure
02/20/2003US20030036517 Identifying accessible regions in a target RNA molecule using trans-splicing nucleic acid molecules
02/20/2003US20030036509 TGF-alpha polypeptides, functional fragments and methods of use therefor
02/20/2003US20030036185 Novel amino acid sequences for human kidney cadherin-like polypeptides
02/20/2003US20030036175 Depletion or removal of endotoxins from solution; obtain solution, incubate with chromatographic column, elute, recover endotoxin free solution
02/20/2003US20030036174 Hair follicle growth factor proteins
02/20/2003US20030036173 Controlling gene expression in living cells
02/20/2003US20030036172 Polypeptide for use in the treatment of cancerous, angiogenesis, inflammatory shock and autoimmune diseases
02/20/2003US20030036171 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
02/20/2003US20030036170 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
02/20/2003US20030036166 ErbB4 receptor-specific neuregulin related ligands and uses therefor
02/20/2003US20030036112 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of nervous system and tumor disorders
02/20/2003US20030036088 Separation of viruses in sample; obtain sample containing viruses, incubate with filter, recover and analyze preferential virus from filter
02/20/2003US20030036078 P5CRs as modifiers of the p53 pathway and methods of use
02/20/2003US20030036076 CADs as modifiers of the p53 pathway and methods of use
02/20/2003US20030035829 Liposomal compositions for the delivery of nucleic acid catalysts
02/20/2003US20030035816 Soluble ctla4 mutant molecules and uses thereof
02/20/2003US20030035814 Cloning Dna; prevention reproduction; gene therapy
02/20/2003US20030035794 Gene-therapeutic nucleic acid construct, production of same and use of same in the treatment of heart disorders
02/20/2003US20030035793 Novel immune response targeting molecules
02/20/2003US20030035792 Recombinant MVA virus, and the use thereof
02/20/2003US20030035791 Modulation of p57kip2 expression and uses thereof in the treatment of diabetes and hyperinsulinism of infancy
02/20/2003US20030035790 Anticancer agents, antinflamamtory agents, infection therapy
02/20/2003US20030035775 Inhalation administering; mixture of drug and solvent
02/20/2003CA2456928A1 Cellular virus receptors and methods of use
02/20/2003CA2456802A1 Composite superimmunogen for bi-functional vaccine use for the treatment of illnesses associated with a stromal tissue disorder
02/20/2003CA2456369A1 Proteins associated with cell growth, differentiation, and death
02/20/2003CA2456295A1 Modulation of antibody formation in mammals, applicability in gene therapy and animal model generation
02/20/2003CA2456247A1 Use of il-18 inhibitors in hypersensitivity disorders
02/20/2003CA2455498A1 Antisense modulation of apolipoprotein(a) expression
02/20/2003CA2455424A1 Compositions and methods for the prevention and treatment of huntington's disease
02/20/2003CA2453248A1 Compositions and methods for the therapy and diagnosis of breast cancer
02/20/2003CA2452488A1 Electrodes coated with treating agent and uses thereof
02/20/2003CA2451919A1 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
02/19/2003EP1284294A1 Novel recombinant adenovirus vector with relieved side effects
02/19/2003EP1284292A2 Human B-cell Translocation Gene-3
02/19/2003EP1284290A1 Increase of the expression levels of factor VIII by insertion of spliceable nucleotide sequences into factor VIII cDNA
02/19/2003EP1284289A1 Method of examining allergic disease
02/19/2003EP1283905A2 Diagnosis of diseases associated with the cell cycle
02/19/2003EP1283895A2 Retroviral vectors comprising an enhanced 3' transcription termination structure
02/19/2003EP1283894A1 Use of baculovirus vectors in gene therapy
02/19/2003EP1283886A2 Intracellular signaling proteins
02/19/2003EP1283885A2 Compositions and methods for the therapy and diagnosis of breast cancer
02/19/2003EP1283882A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
02/19/2003EP1283874A2 Novel deoxynucleoside kinase enzyme variants
02/19/2003EP1283848A2 Protein complexes and assays for screening anti-cancer agents
02/19/2003EP1283726A2 Dendritic cells loaded with toxic substances
02/19/2003EP1283718A2 Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine
02/19/2003CN1398297A Recombinant flaviviruses and methods of use thereof
02/18/2003US6521750 Nucleotide sequence coding human protein for use in treatment of osteoporosis and bone disorders
02/18/2003US6521602 Anti-neoplastic compositions and uses thereof
02/18/2003US6521457 Lentivirus-based gene transfer vectors
02/18/2003US6521456 Gene therapy for cancer; treating viral infections, nervous system disorders, graft rejection, and monogenic or polygenic disorders
02/18/2003US6521455 Viral polypeptide for use as tool in genetic engineering and gene therapy
02/18/2003US6521449 Enhancer from immunoglobulin; polyadenylation site; gene therapy
02/18/2003US6521448 Porcine MHC class I genes and uses thereof
02/18/2003US6521441 Staphylococcus aureus genes and polypeptides
02/18/2003US6521439 Nucleic acids encoding plasminogen fragments
02/18/2003US6521422 Fhm, a novel member of the TNF ligand supergene family
02/18/2003US6521417 Incubating permeabilized cells expressing mutant kinase with radiolabeled analog; cytolysis, separation by sodium dodecyl sulfate polyacrylamide gel electrophoresis
02/18/2003US6521412 Drug screening for anticarcinogenic agents and agents to treat atherosclerosis and neurodegenerative disorders
02/18/2003US6521252 Comprises one or several disulphide bonds; cationic lipid type
02/18/2003US6521235 Alphavirus RNA replicon systems
02/18/2003US6521226 Administering Paraoxonase-1 (PON-1), an expressed protein that has hydrolase activity for organophosphates, and antioxidation activity for low-density lipoprotein (LDL)
02/18/2003US6521225 AAV vectors
02/17/2003CA2356390A1 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof
02/13/2003WO2003012112A1 Methylation resistant vectors
02/13/2003WO2003012111A2 Conjugates for the modulation of immune responses
02/13/2003WO2003012105A2 Vegf isoform
02/13/2003WO2003012093A2 Regulator of calcineurin
02/13/2003WO2003012086A1 Antigen presenting cells, method for their preparation and their use for cancer vaccines
02/13/2003WO2003012085A1 Antigen presenting cells, method for their preparation and their use for cancer vaccines
02/13/2003WO2003012082A2 Method for modulating stem cell differentiation using stem loop rna
02/13/2003WO2003012059A2 Antisense modulation of cyclin d2 expression
02/13/2003WO2003012051A2 Inhibitor of dna methylation
02/13/2003WO2003012050A2 Mitochondrial genome replenishment
02/13/2003WO2003012049A2 Methods and composition concerning herpes virus us3 and bad-involved apoptosis
02/13/2003WO2003012043A2 Enhancing organ maturity in neonates and predicting their duration of intensive care
02/13/2003WO2003012039A2 Targeting nucleic acids to a cellular nucleus
02/13/2003WO2003012030A2 Isoform-selective inhibitors and activators of pde3 cyclic
1 ... 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 ... 870